Hospital Introduction & Medical Care Guide

Zhejiang Provincial People's Hospital (ZJPPH) was established in 1984 as a large comprehensive Grade 3 Class A hospital directly under the Zhejiang Provincial Health Commission and a teaching hospital of Zhejiang University School of Medicine. Upholding the core values of "Benevolence, Excellence, Dedication, and Innovation," the hospital follows the development theme of "Building Peaks, Strengthening Breadth, and Group Development." It ranked 25th in the 2022 national tertiary public hospital performance assessment, maintaining A+ rating for five consecutive years. The hospital currently operates four campuses (Zhaohui, Wangjiangshan, Yuecheng/Shaoxing, and Bijie) covering a total area of 186,000 square meters with over 3,000 open beds. As one of the first pilot hospitals for multidisciplinary tumor diagnosis and treatment in China, it leads provincially in minimally invasive surgery, organ transplantation (heart, kidney, bone marrow, and cornea), critical care medicine, and interventional diagnosis and treatment. In 2024, it released Medical AI Agent Cluster 1.0, and in 2025 established a Brain-Computer Interface and Neuromodulation Clinical Research Ward, continuing innovation in smart healthcare and neuroscience frontiers.

微创外科（Minimally Invasive Surgery），器官移植（Organ Transplantation），肿瘤综合治疗（Comprehensive Cancer Treatment）

微创外科（Minimally Invasive Surgery），器官移植中心（Organ Transplant Center），肿瘤科（Oncology），泌尿外科（Urology），心胸外科（Cardiothoracic Surgery），危重病医学科（Intensive Care Medicine），眼科（Ophthalmology），康复医学（Rehabilitation Medicine）

National Status and International Recognition
1. National Ranking: Ranked 25th nationwide in the 2022 national tertiary public hospital performance assessment, maintaining A+ rating for five consecutive years.
2. National Clinical Key Specialties: 4 national clinical key specialties (General Surgery, Oncology, Urology, Clinical Nursing), 1 provincial key discipline cluster (Minimally Invasive Surgery Cluster), 8 provincial key disciplines (Cardiothoracic Surgery, General Surgery, Minimally Invasive Surgery, Critical Care Medicine, Radiology, Gastrointestinal Surgery, Clinical Laboratory, Clinical Pathology).
3. National Pilot Hospitals: First batch of national multidisciplinary tumor diagnosis and treatment pilot hospitals, first batch of national public hospital party building demonstration hospitals.
4. Research Platforms: 2 provincial/ministerial-level key laboratories (Zhejiang Provincial Gastroenterology Key Laboratory, Zhejiang Provincial Organ Transplantation Key Research Laboratory Cardiac Transplantation Branch), 6 first-batch Ministry of Health endoscopy diagnosis and treatment technology training bases (General Surgery, Gynecology, Orthopedics, Urology, Gastroenterology, Congenital Heart Intervention).
5. Honors: National Civilized Unit, National Safe Hospital, National High-Quality Medical Service Demonstration Hospital, National Advanced Collective in COVID-19 Response, Hangzhou Asian (Para) Games Advanced Collective.
6. Frontier Innovation: Released Medical AI Agent Cluster 1.0 in 2024 (management, medical technology, clinical full coverage); established Brain-Computer Interface and Neuromodulation Clinical Research Ward in 2025, collaborating with multiple disciplines for nervous system disease research.

Core Departments and Leadership Advantages
1. Minimally Invasive Surgery/General Surgery: National clinical key specialty, core of Zhejiang Provincial Minimally Invasive Surgery Discipline Cluster. Minimally invasive surgery techniques cover general surgery, thoracic surgery, orthopedics, urology, gynecology, leading provincially.
2. Organ Transplantation Center: Conducts heart transplantation, living-related kidney transplantation, bone marrow transplantation, corneal transplantation, with Zhejiang Provincial Organ Transplantation Key Research Laboratory Cardiac Transplantation Branch.
3. Oncology: National clinical key specialty, first batch national multidisciplinary tumor diagnosis and treatment pilot hospital, forming multidisciplinary collaborative models in comprehensive oncology.
4. Urology: National clinical key specialty, leading in minimally invasive treatment of urinary tumors and prostate disease diagnosis and treatment.
5. Cardiothoracic Surgery: Provincial key discipline, provincially leading in heart transplantation, complex congenital heart disease intervention, and thoracoscopic surgery.
6. Critical Care Medicine: Provincial key discipline, leading in severe infection and multi-organ function support.
7. Ophthalmology: Nationally advanced in corneal transplantation, refractive surgery, and vitreoretinal surgery.
8. Rehabilitation Medicine: Wangjiangshan Campus features chronic diseases, geriatrics, and rehabilitation, accomplished in stroke hemiplegia, joint diseases, and postoperative functional rehabilitation.